Neuland Laboratories Ltd

Neuland Labs. | 524558

Live

₹19,506.00

₹35.17 (-0.18%)

As on 10/07/26, 6:57 PM

Market Cap25,072.17 CR

Current Price₹19,506

High / Low₹20,089 / 11,500

PE Ratio59.9

Book Value₹1,181.32

Dividend Yield0.10%

ROCE18.58%

ROE14.86%

Face Value₹2.00

Current Vol.24,863

Average Vol.---

ISININE794A01010

PB Ratio10.22

Debt to Equity0.09

Net Profit Margin14.1

Operating Margin23.77

Share Price Chart - Neuland Laboratories Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹19,542₹19,701

₹19,506

Previous CloseToday's Open

₹11,500₹20,089

₹19,506

52W Low52W High

₹19,701Today's Open

₹19,542Previous Close

24,863Volume

₹11,50052W Low

₹20,08952W High

Ratios

No data available

About Company

Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao
The Company is engaged in manufacturing and selling of bulk drugs such as Salbutamol Sulphate, Terbutaline Sulphate, Labetalol Hydrochloride and Ciprofloxacin
Neuland Drugs & Pharmaceuticals Pvt
, a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992
NLL manufactures bulk drugs
The Company came out with its initial public offering in Apr
'94 at a premium of Rs 35 aggregating Rs 5
69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix
The cost of the project as estimated by ICICI was Rs 15
NLL's products are exported to more than 35 countries including Germany, Italy, Switzerland, the UK and the Netherlands

Ethics: Neuland Laboratories Ltd is flagged for

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Adequate

---

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI78.12

SMA 2018028.05

SMA 5017199.54

SMA 10015249.06

SMA 20015395.62

SMA 1018763.30

MACD_12_26_Days647.30

EMA10Day18753.71

EMA20Day18236.24

EMA50Day17158.72

MACD_12_26_9_Days89.61

EMA100Day16153.15

EMA200Day15319.21

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth-5.24%

ROE14.84%

EBITDA Margin23.77%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	1,476.84	1,558.58	1,191.20	951.08	936.91
Interest	8.30	14.00	13.07	13.50	17.90
Expenses	1,153.58	1,095.99	919.36	808.46	790.09
Financing Profit	343.77	475.13	281.59	144.70	162.91
Financing Margin %	23%	30%	24%	15%	17%
Other Income	20.51	12.54	9.75	2.08	16.10
Depreciation	65.55	59.70	52.78	49.04	39.68
Profit before tax	346.33	401.44	215.75	82.16	105.33
Tax %	25%	25%	24%	22%	23%
Net Profit	260.11	300.08	163.52	63.82	80.63
EPS in Rs	202.74	233.89	127.45	49.74	62.85

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
AIRAVAT CAPITAL TRUST II	05 Sept ‘25	Purchase	8,896	₹14,612	12.36%
AIRAVAT CAPITAL TRUST	05 Sept ‘25	Sell	8,896	₹14,612	12.36%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

24 Jul 2026

Final Dividend (₹34)

Recommended payment of final dividend of Rs. 34/- (340 %) per equity share on a face value of Rs.10 each, for the financial year 2025-26. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 42nd Annual General Meeting (AGM).

12 May 2026

30 Jul 2025

AGM

15 May 2025

18 Jul 2025

Final Dividend (₹12)

Recommended payment of final dividend of Rs. 12/- (120 %) per equity share on a face value ofRs.10 each, for the financial year 2024-25. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 41st Annual General Meeting (AGM). Pursuant to Regulation 42 of SEBI Listing Regulations the record date for the purpose of determining the shareholders eligible to receive the final dividend for the financial year ended March 31, 2025, has been fixed as July 18, 2025.

15 May 2025

31 Jul 2024

AGM

10 May 2024

13 Jul 2024

Final Dividend (₹14)

Recommendation of final dividend for the financial year 2023-24

10 May 2024

27 Jul 2023

AGM

11 May 2023

12 Jul 2023

Final Dividend (₹10)

Outcome of Board Meeting held on May 11, 2023 - Audited Financial Results and recommendation of Final Dividend for financial year 2022-2023

11 May 2023

02 Aug 2022

AGM

17 Jun 2022

15 Jul 2022

Final Dividend (₹5)

Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2022, inter alia, have recommended payment of final dividend of Rs. 5.00/- (50%) per equity share on a face value of Rs.10 each, subject to the approval of members of the Company.

10 May 2022

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
19,519	25,043	69	13	55	0	14.10%
1,939	4,65,195	37	6	30	0	19.78%
6,811	1,80,823	69	11	59	0	23.41%
4,897	1,65,725	76	20	50	1	11.09%
1,442	1,16,467	31	3	23	0	9.92%
1,160	1,15,695	21	4	17	0	19.86%
2,503	1,14,441	20	5	16	0	14.56%
1,270	1,05,987	26	3	17	0	12.34%
2,531	1,04,544	52	6	36	0	14.39%
1,587	92,144	26	2	17	0	10.98%

Showing 10 of 134 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Neuland Laboratories Ltd?

The current share price of Neuland Laboratories Ltd (Neuland Labs.) is ₹19506.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Neuland Laboratories Ltd?

The Price-to-Earnings (P/E) ratio of Neuland Laboratories Ltd is 19506.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Neuland Laboratories Ltd?

Neuland Laboratories Ltd has a 52-week high of ₹20089.00 and a 52-week low of ₹11500.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Neuland Laboratories Ltd?

Neuland Laboratories Ltd offers a dividend yield of 0.17%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Neuland Laboratories Ltd?

The Earnings Per Share (EPS) of Neuland Laboratories Ltd is ₹283.71. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Neuland Laboratories Ltd?

Neuland Laboratories Ltd has a Return on Equity (ROE) of 14.86%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video